PONIARD PHARMACEUTICALS, INC.
PONIARD PHARMACEUTICALS, INC. (PARD) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 299 transactions totaling $38.6M, demonstrating a bullish sentiment with $14.1M in net insider flow. The most recent transaction on Mar 27, 2012 involved a sale of 257 shares valued at $213.
PARD Insider Activity Summary
Who Is Buying PARD Stock?
No significant insider buying has been recorded for PARD in the recent period.
Who Is Selling PARD Stock?
No significant insider selling has been recorded for PARD in the recent period.
Is PONIARD PHARMACEUTICALS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PARD is bullish with an Insider Alignment Score of 68/100 and a net flow of $14.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
PARD Frequently Asked Questions
Understanding PARD Insider Activity
Insider trading at PONIARD PHARMACEUTICALS, INC. (PARD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading PARD stock, having executed 299 transactions in the past 90 days. The most active insider is Nicholas J. Simon III (Executive), who has made 5 transactions totaling $9.7M.
Related Tools
Track PONIARD PHARMACEUTICALS, INC. Insider Activity
Get notified when executives and directors at PARD file new Form 4 transactions